Cellular and molecular mechanisms of metformin: an overview
Open accessThe DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Abstract
Considerable efforts have been made since the 1950s to better understand the cellular and molecular mechanisms of action of metformin, a potent antihyperglycaemic agent now recommended as the first-line oral therapy for T2D (Type 2 diabetes). The main effect of this drug from the biguanide family is to acutely decrease hepatic glucose production, mostly through a mild and transient inhibition of the mitochondrial respiratory chain complex I. In addition, the resulting decrease in hepatic energy status activates AMPK (AMP-activated protein kinase), a cellular metabolic sensor, providing a generally accepted mechanism for the action of metformin on hepatic gluconeogenesis. The demonstration that respiratory chain complex I, but not AMPK, is the primary target of metformin was recently strengthened by showing that the metabolic effect of the drug is preserved in liver-specific AMPK-deficient mice. Beyond its effect on glucose metabolism, metformin has been reported to restore ovarian function in PCOS (polycystic ovary syndrome), reduce fatty liver, and to lower microvascular and macrovascular complications associated with T2D. Its use has also recently been suggested as an adjuvant treatment for cancer or gestational diabetes and for the prevention in pre-diabetic populations. These emerging new therapeutic areas for metformin will be reviewed together with recent findings from pharmacogenetic studies linking genetic variations to drug response, a promising new step towards personalized medicine in the treatment of T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In PCOS, metformin reduces insulin resistance and inhibits ovarian androgen production via effects on steroidogenic acute regulatory protein and 17alphahydroxylase (Diamanti-Kandarakis et al. , 2010; Viollet et al. , 2012).”
From Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis (2015) · cites this paper as Viollet et al., 2012
The cited source says what the claim attributes to it.
In the citing paper
“a drug that is currently being used to treat type II diabetic patients, metformin [74], can activate AMPK”
From Senescence of T Lymphocytes: Implications for Enhancing Human Immunity (2016) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“Given the evidence that metformin acts through the mitochondrial electron transport chain (ETC) by inhibiting complex I(46, 210–212) (Figure 8)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [46]
In the citing paper
“By far the most important mechanism is the reduction in hepatic glucose production that is considered mediated by the activation of the global energy sensor in cells, adenosine monophosphate-activated protein kinase (AMPK) (Figure 1).(46)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 4×
“Thus, AMPK activation by metformin induces the phosphorylation and inactivation of acetyl CoA carboxylase (ACC), an important rate-controlling enzyme for the synthesis of malonylCoA, which is both a critical precursor for the biosynthesis of fatty acids and a potent inhibitor of mitochondrial fatty acid oxidation [17].”
BackgroundInfluentialHyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · cited 1×
“Furthermore, the authors found a doseresponse relationship between duration of exposure to metformin and cancer incidence [106].”
BackgroundGiovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950 · cited 25×
“Metformin most likely does not directly activate either LKB1 or AMPK as the drug does not influence the phosphorylation of AMPK by LKB1 in cell-free assay [21].”
BackgroundInfluential
Cited by
Items 401–500 of 1,001
Westhaus, A., Blumrich, E. M., & Dringen, R. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1733-8 · Cited by 56
Metformin-Associated Lactic Acidosis: Predisposing Factors and Outcome
Kim, M. J., Han, J. Y., Shin, J. Y., Kim, S. I., Lee, J. M., Hong, S., Kim, S. H., Nam, M. S., & Kim, Y. (2015) · Endocrinology and Metabolism · doi:10.3803/enm.2015.30.1.78 · Cited by 51
Tseng, C. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011640 · Cited by 51
Neopterin and biopterin levels and tryptophan degradation in patients with diabetes
GÜRCÜ, S., Girgin, G., Yorulmaz, G., Kılıçarslan, B., Efe, B., & Baydar, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-74183-w · Cited by 53
Biguanides drugs: Past success stories and promising future for drug discovery
Grytsai, O., Myrgorodska, I., Rocchi, S., Ronco, C., & Benhida, R. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113726 · Cited by 51
Yandrapalli, S., Jolly, G., Horblitt, A., Sanaani, A., & Aronow, W. S. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1358064 · Cited by 50
Nutrition and Obesity in the Pathogenesis of Youth-Onset Type 1 Diabetes and Its Complications
March, C. A., BECKER, D. J., & Libman, I. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.622901 · Cited by 52
Novel approaches to drug discovery for the treatment of type 2 diabetes
Xu, X. Y., Wang, G., Zhou, T., Chen, L., Chen, J., & Shen, X. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.941352 · Cited by 52
Doycheva, I., & Loomba, R. S. (2014) · Advances in Therapy · doi:10.1007/s12325-013-0084-6 · Cited by 53
Tyszka‐Czochara, M., Bukowska-Straková, K., & Majka, M. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.05.065 · Cited by 50
Gestational diabetes mellitus: Multi-disciplinary treatment approaches
Kintiraki, E., & Goulis, D. G. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.025 · Cited by 56
Zake, D. M., Kurlovičs, J., Zaharenko, L., Komašilovs, V., Kloviņš, J., & Stalidzāns, E. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249594 · Cited by 51
Chen, Q., Cao, T., Li, N., Zeng, C., Zhang, S., Wu, X., Zhang, B., & Cai, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.667874 · Cited by 57
Damanhouri, Z. A., Alkreathy, H. M., Alharbi, F. A., Abualhamail, H., & Ahmad, M. S. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.77206 · Cited by 58
THERAPY OF ENDOCRINE DISEASE: Treatment of hirsutism in the polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0585 · Cited by 49
Chen, Z.-F., Shen, Y., Gao, D., Lin, D.-F., Ma, W., & Chang, D. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00074.2025 · Cited by 60
Prediction and validation of enzyme and transporter off-targets for metformin
Yee, S. W., Lin, L., Merski, M., Keiser, M. J., Gupta, A., Zhang, Y., Chien, H.-C., Shoichet, B. K., & Giacomini, K. M. (2015) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-015-9436-y · Cited by 49
microRNAs and cancer metabolism reprogramming: the paradigm of metformin.
Pulito, C., Donzelli, S., Muti, P. C., Puzzo, L., Strano, S., & Blandino, G. (2014) · PubMed · doi:10.3978/j.issn.2305-5839.2014.06.03 · Cited by 54
AMP-activated protein kinase regulation of kidney tubular transport
Pastor‐Soler, N. M., & Hallows, K. R. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283562390 · Cited by 49
Xie, W., Wang, L., Sheng, H., Qiu, J. Y., Zhang, D., Zhang, L., Yang, F., Tang, D., & Zhang, K. (2017) · Medical Science Monitor · doi:10.12659/msm.898710 · Cited by 53
Contemporary approaches to the management of polycystic ovary syndrome
Pasquali, R. (2018) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018818756790 · Cited by 63
Jiang, W., Zhang, C., Ahmed, A., Zhao, Y., Deng, Y., Ding, Y., Cai, J., & Hu, Y. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900972 · Cited by 49
Docrat, T. F., Nagiah, S., Naicker, N., Baijnath, S., Singh, S. D., & Chuturgoon, A. A. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173059 · Cited by 52
Yang, H., Garzel, B., Heyward, S. A., Moeller, T. A., Shapiro, P., & Wang, H. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.089763 · Cited by 49
Silvestri, A., Palumbo, F., Rasi, I., Posca, D., Pavlidou, T., Paoluzi, S., Castagnoli, L., & Cesareni, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136250 · Cited by 50
Treviño, S., Sánchez‐Lara, E., Sarmiento-Ortega, V. E., Sánchez‐Lombardo, I., Flores-Hernández, J. Á., Pérez-Benítez, A., Brambila, E., & Vergara, E. G. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2015.04.002 · Cited by 53
LKB1 tumor suppressor: Therapeutic opportunities knock when LKB1 is inactivated
Zhou, W., Zhang, J., & Marcus, A. I. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.06.002 · Cited by 51
Tsai, C., Kuo, H.-C., Hsu, C., Huang, L., & Tain, Y. (2014) · Translational research · doi:10.1016/j.trsl.2014.07.005 · Cited by 48
Uçaktürk, E. (2013) · Analytical Methods · doi:10.1039/c3ay40507a · Cited by 48
Ghadge, A. A., & Kuvalekar, A. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.08.009 · Cited by 55
Khan, A., Shafiq`, I., & Shah, M. H. (2017) · Cureus · doi:10.7759/cureus.1577 · Cited by 59
A Review on The Protective Effects of Metformin in Sepsis-Induced Organ Failure.
Hassan, F. I., Didari, T., Khan, F., Niaz, K., Mojtahedzadeh, M., & Abdollahi, M. R. (2020) · PubMed Central · doi:10.22074/cellj.2020.6286 · Cited by 54
Blumenberg, A., Benabbas, R., Sinert, R. H., Jeng, A., & Wiener, S. W. (2020) · Journal of Medical Toxicology · doi:10.1007/s13181-019-00755-6 · Cited by 48
Mitochondria in Early Forebrain Development: From Neurulation to Mid-Corticogenesis
Fame, R. M., & Lehtinen, M. K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.780207 · Cited by 51
Jahandideh, F., & Wu, J. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.06.001 · Cited by 52
Atangwho, I. J., Khoo, B. Y., Umar, M. I., Ahmad, M., & Asmawi, M. Z. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-426 · Cited by 47
Jensterle, M., Kocjan, T., & Janez, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1430 · Cited by 44
Di Magno, L., Basile, A., Coni, S., Manni, S., Sdruscia, G., D’Amico, D., Antonucci, L., Infante, P., De Smaele, E., Cucchi, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7070 · Cited by 45
Metformin exhibits preventive and therapeutic efficacy against experimental cystic echinococcosis
Loos, J. A., Dávila, V. A., Rodrígues, C. R., Petrigh, R. S., Zoppi, J. A., Crocenzi, F. A., & Cumino, A. C. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005370 · Cited by 53
Aldamri, N. T., Attia, H., Al‐Rasheed, N. M., Al-Rasheed, N. M., Mohamad, R. A., Alamin, M. A., Dizmiri, N., & Atteya, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.126 · Cited by 52
Repurposing of Drugs Targeting YAP-TEAD Functions
Elisi, G. M., Santucci, M., D’Arca, D., Lauriola, A., Marverti, G., Losi, L., Scalvini, L., Bolognesi, M. L., Mor, M., & Costi, M. P. (2018) · Cancers · doi:10.3390/cancers10090329 · Cited by 51
Bhansali, S., Bhansali, A., & Dhawan, V. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14141 · Cited by 44
Targeting the Inositol Pyrophosphate Biosynthetic Enzymes in Metabolic Diseases
Mukherjee, S., Haubner, J., & Chakraborty, A. (2020) · Molecules · doi:10.3390/molecules25061403 · Cited by 45
Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease?
Mazzotti, A., Caletti, M. T., Marchignoli, F., Forlani, G., & Marchesini, G. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.12.028 · Cited by 46
Cognitive function in metformin exposed children, born to mothers with PCOS – follow-up of an RCT
Greger, H. K., Hanem, L. G. E., Østgård, H. F., & Vanky, E. (2020) · BMC Pediatrics · doi:10.1186/s12887-020-1960-2 · Cited by 46
Yuan, F., Cheng, C., Xiao, F., Liu, H., Cao, S., & Zhou, G. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117276 · Cited by 48
Metformin and ovarian cancer: the evidence
Urpilainen, E., Puistola, U., Boussios, S., & Karihtala, P. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-1060 · Cited by 47
Chang, J., & Choi, M. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238960 · Cited by 50
Zhang, D., Ma, Y., Liu, J., Deng, Y., Zhou, B., Wen, Y., Li, M., Wen, D.-Y., Ying, Y., Luo, S., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.689111 · Cited by 48
Chen, Y., Yang, Y., Liu, Z., & He, L. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154959 · Cited by 48
Pharmacogenetics and personalized treatment of type 2 diabetes
Semiz, S., Dujić, T., & Čaušević, A. (2013) · Biochemia Medica · doi:10.11613/bm.2013.020 · Cited by 54
New treatments for autosomal dominant polycystic kidney disease
Chang, M., & Ong, A. C. M. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12136 · Cited by 49
Saad, M. I., Kamel, M. A. E.-N., & Hanafi, M. Y. (2015) · Biochemistry Research International · doi:10.1155/2015/138134 · Cited by 50
Metformin Protects Rat Hepatocytes against Bile Acid-Induced Apoptosis
Woudenberg-Vrenken, T. E., de la Rosa, L. C., Buist‐Homan, M., Faber, K. N., & Moshage, H. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071773 · Cited by 45
Liu, Z., Qi, S., Ζhao, X., Li, M., Ding, S., Lü, J., & Zhang, H. (2016) · Oncotarget · doi:10.18632/oncotarget.7040 · Cited by 45
Cancer: Untethering Mitochondria from the Endoplasmic Reticulum?
Herrera-Cruz, M. S., & Simmen, T. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00105 · Cited by 47
Arbeláez-Quintero, I., & Palacios, M. (2017) · Stroke Research and Treatment · doi:10.1155/2017/9756429 · Cited by 50
Sebaiy, M. M., El-Adl, S. M., Baraka, M. M., & Hassan, A. A. (2019) · Acta Chromatographica · doi:10.1556/1326.2018.00515 · Cited by 54
Wattamwar, T., Mungantiwar, A., Halde, S., & Pandita, N. S. (2019) · European Journal of Mass Spectrometry · doi:10.1177/1469066719879297 · Cited by 45
Joe, S. G., Yoon, Y. H., Choi, J. A., & Koh, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119708 · Cited by 45
Convergence of IPMK and LKB1-AMPK Signaling Pathways on Metformin Action
Bang, S., Chen, Y., Ahima, R. S., & Kim, S. F. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1134 · Cited by 45
Role of Gut Microbial Metabolites in Cardiovascular Diseases—Current Insights and the Road Ahead
Datta, S., Pasham, S., Sandeep, I. S., Boini, K. M., & Koka, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810208 · Cited by 46
Kim, T. H., Suh, D. H., Kim, M., & Song, Y. S. (2014) · BioMed Research International · doi:10.1155/2014/132702 · Cited by 47
Vissers, P. A. J., Cardwell, C. R., van de Poll-Franse, L. V., Young, I. S., Pouwer, F., & Murray, L. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3331-5 · Cited by 44
Carbone, S., Dixon, D. L., Buckley, L. F., & Abbate, A. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.07.018 · Cited by 45
Kongsuphol, P., Gupta, S., Liu, Y., Gourikutty, S. B. N., Biswas, S. K., & Ramadan, Q. (2019) · Scientific Reports · doi:10.1038/s41598-019-41338-3 · Cited by 45
Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis
Abreu, R. B., Giri, P. K., & Quinn, F. D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01553 · Cited by 47
Pateliya, B., BURADE, V. S., & Goswami, S. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173725 · Cited by 46
Heinonen, S. E., Genové, G., Bengtsson, E., Hübschle, T., Åkesson, L., Hiss, K., Benardeau, A. M., Ylä‐Herttuala, S., Jönsson‐Rylander, A., & Gomez, M. F. (2015) · Journal of Diabetes Research · doi:10.1155/2015/404085 · Cited by 44
The Gut Microbiota-Related Antihyperglycemic Effect of Metformin
Szymczak-Pajor, I., Drzewoski, J., Kozłowska, M., Krekora, J., & Śliwińska, A. (2025) · Pharmaceuticals · doi:10.3390/ph18010055 · Cited by 45
Metabolaging: a new geroscience perspective linking aging pathologies and metabolic dysfunction
Khalaf, F., Barayan, D., Saldanha, S., & Jeschke, M. G. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156158 · Cited by 45
Fu, L., Bruckbauer, A., Li, F., Cao, Q., Cui, X., Wu, R., Shi, H., Zemel, M. B., & Xue, B. (2015) · Metabolism · doi:10.1016/j.metabol.2015.03.007 · Cited by 44
Kim, B., Kim, M.-S., & Hyun, C. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.003 · Cited by 45
Geniposide and Gentiopicroside Suppress Hepatic Gluconeogenesis via Regulation of AKT-FOXO1 Pathway
Yang, S., Chen, Y.-D., Li, H., Hui, X., & Gao, W. (2018) · Archives of Medical Research · doi:10.1016/j.arcmed.2018.10.005 · Cited by 44
Geroneuroprotectors: Effective Geroprotectors for the Brain
Schubert, D. A., Currais, A. J. M., Goldberg, J., Finley, K. D., Petrascheck, M., & Maher, P. A. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.09.008 · Cited by 43
Li, X., Chen, Y., Shen, Z., Pan, Q., Yang, W., Yan, H., Liu, H., Ai, W., Liao, W., & Guo, S. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b00395 · Cited by 43
Near-infrared light activatable hydrogels for metformin delivery
Li, C., Pagneux, Q., Voronova, A., Barras, A., Abderrahmani, A., Plaisance, V., Pawlowski, V., Hennuyer, N., Staels, B., Rosselle, L., et al. (2019) · Nanoscale · doi:10.1039/c9nr02707f · Cited by 44
Metformin and cognition from the perspectives of sex, age, and disease
Chaudhari, K., Reynolds, C. D., & Yang, S.-H. (2020) · GeroScience · doi:10.1007/s11357-019-00146-3 · Cited by 44
Saenwongsa, W., Nithichanon, A., Chittaganpitch, M., Buayai, K., Kewcharoenwong, C., Thumrongwilainet, B., Butta, P., Palaga, T., Takahashi, Y., Ato, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60213-0 · Cited by 46
Moderate Caloric Restriction Partially Improved Oxidative Stress Markers in Obese Humans
Kanikowska, D., Kanikowska, A., Swora-Cwynar, E., Grzymislawski, M. B., Sato, M., Bręborowicz, A., Witowski, J., & Korybalska, K. (2021) · Antioxidants · doi:10.3390/antiox10071018 · Cited by 44
Kuś, E., Zabielski, P., Kochan, K., Kuś, K., Jasztal, A., Sitek, B., Proniewski, B., Wójcik, T., Gula, K., Kij, A., et al. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.12.004 · Cited by 44
The Role of Fenugreek in the Management of Type 2 Diabetes
Haxhiraj, M., White, K., & Terry, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136987 · Cited by 54
Śmieszek, A., Czyrek, A. A., Basińska, K., Trynda, J., Skaradzińska, A., Siudzińska, A., Marędziak, M., & Marycz, K. (2015) · BioMed Research International · doi:10.1155/2015/769402 · Cited by 48
Metformin Suppresses Pancreatic Tumor Growth With Inhibition of NFκB/STAT3 Inflammatory Signaling
Tan, X., Bhattacharyya, K. K., Dutta, S. K., Bamlet, W. R., Rabe, K. G., Wang, E., Smyrk, T. C., Oberg, A. L., Petersen, G. M., & Mukhopadhyay, D. (2015) · Pancreas · doi:10.1097/mpa.0000000000000308 · Cited by 49
Zhai, L., Gu, J., Yang, D., Hu, W., Wang, W., & Ye, S. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12437 · Cited by 42
Pineda-Ramírez, N., Aguilar, G. F. G., Espinoza-Rojo, M., & Aguilera, P. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1284361 · Cited by 42
The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality?
Castagnola, S., Bardoni, B., & Maurin, T. (2017) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2017.00015 · Cited by 40
Alomar, S. Y., Barakat, B. M., Eldosoky, M., Atef, H., Mohamed, A. S., Elhawary, R., El‐Shafey, M., Youssef, A. M., Elkazaz, A. Y., Gabr, A. M., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107193 · Cited by 42
RetractedShoshan‐Barmatz, V., Anand, U., Crystal, E. N., Carlo, M. D., & Shteinfer‐Kuzmine, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.730048 · Cited by 44
He, M., Lu, B., Opoku, M., Zhang, L., Xie, W., Jin, H., Chen, S., Li, Y., & Deng, Z. (2022) · Cells · doi:10.3390/cells11193012 · Cited by 43
Mechanisms of current therapies for diabetes mellitus type 2
Thulé, P. M. (2012) · Advances in Physiology Education · doi:10.1152/advan.00094.2012 · Cited by 40
Cheng, F., He, M., Jung, J. U., Lu, C., & Gao, S. (2016) · Journal of Virology · doi:10.1128/jvi.00624-16 · Cited by 44
Gu, J., Ye, S., Wang, S., Sun, W., & Hu, Y. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20132781 · Cited by 42
Hung, C., Chan, S., Chu, P., Lin, H.-C., & Tsai, K. (2016) · Oncotarget · doi:10.18632/oncotarget.7387 · Cited by 45
Impact of 5'-amp-activated Protein Kinase on Male Gonad and Spermatozoa Functions
Nguyen, T. M. D. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00025 · Cited by 45
Qi, X., Guo, Y., Song, Y., Yu, C., Zhao, L., Li, F., Kong, D., Zhao, J., & Gao, L. (2018) · Diabetologia · doi:10.1007/s00125-018-4562-x · Cited by 43
Ishino, K., Kudo, M., Peng, W., Kure, S., Kawahara, K., Teduka, K., Kawamoto, Y., Kitamura, T., Fujii, T., Yamamoto, T., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.041 · Cited by 41
Ramos-Peñafiel, C. O., Olarte-Carrillo, I., Maldonado, R. C., Rozen‐Fuller, E., Kassack-Ipiña, J. J., Meléndez, G., Collazo-Jaloma, J., & Martínez‐Tovar, A. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1620-6 · Cited by 42
Li, S.-M. H., Liu, S., Chang, Y., Ho, C., & Huang, S. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0478-5 · Cited by 41
Nurcahyanti, A. D. R., Jap, A., Lady, J., Prismawan, D., Sharopov, F. S., Daoud, R., Wink, M., & Sobeh, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112138 · Cited by 44
Metadata
- Authors
- Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F.
- Affiliations
- INSERM, U1016, Institut Cochin, Paris, France
- Leiden University Medical Center (NL)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Leclerc, Jocelyne
- Foretz, Marc
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2011-11-11
- Volume
- 122
- Issue
- 6
- Pages
- 253-270
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- PMC
- PMC3398862
- OpenAlex
- W2154024784
- Cited by
- 1,720
- References
- 167
- Citations by year
- 2026: 63 · 2025: 85 · 2024: 96 · 2023: 103 · 2022: 106 · 2021: 143 · 2020: 155 · 2019: 135 · 2018: 141 · 2017: 156 · 2016: 137 · 2015: 144 · 2014: 117 · 2013: 104 · 2012: 34
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Keywords
- metformin, type 2 diabetes, biguanides, AMPK, mitochondrial complex I inhibition, hepatic gluconeogenesis, hepatic glucose production, polycystic ovary syndrome, hepatic steatosis, diabetes complications, adjuvant cancer therapy, gestational diabetes mellitus, prediabetes, pharmacogenetics, personalized medicine
- MeSH terms
- Animals, Cardiovascular System, Diabetic Nephropathies, Female, Humans, Hypoglycemic Agents, Metformin, Neoplasms, Polycystic Ovary Syndrome, Circadian Clocks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.